“…Most studies reported cross‐sectional findings ( n = 17; 44.7%) (Azarbad et al, ; Cachelin et al, ; Fitzgibbon et al, ; Gayle et al, ; Harrington et al, ; Harrington et al, ; Higgins et al, ; Hrabosky & Grilo, ; Jarosz et al, ; Kelly, Cotter, & Mazzeo, ; Lydecker et al, ; Lydecker & Grilo, ; Mazzeo et al, ; Mitchell & Mazzeo, ; Shuttlesworth & Zotter, ; Striegel‐Moore et al, ; Udo et al, ). Additional studies included secondary data analyses of cross‐sectional data ( n = 3; 7.8%) (Adamus‐Leach et al, ; Kelly et al, ; Wilson et al, ), secondary data analyses of population‐based longitudinal studies ( n = 4; 10.5%) (Marcus et al, ; Munn‐Chernoff et al, ; Smith et al, ; Striegel‐Moore et al, ); secondary analyses of large, representative data sets of Black respondents ( n = 4; 10.5%) (Assari, ; Blostein et al, ; Marques et al, ; Taylor et al, ), and secondary analyses of RCT's ( n = 3; 7.8%) (Lydecker et al, ; Mama et al, ; Thompson‐Brenner et al, ). The remaining studies were: (a) a focus group study (Scott et al, ); (b) case–control design studies ( n = 4; 10.3%) (Grilo et al, ; Pike et al, ; Striegel‐Moore et al, ; Striegel‐Moore et al, ); and (c) randomized clinical trials ( n = 2; 5.3%) examining the change in BE over time (Goode et al, ; Grilo et al, ).…”